Marta Medeot

1.1k total citations
17 papers, 541 citations indexed

About

Marta Medeot is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Marta Medeot has authored 17 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Marta Medeot's work include Hematopoietic Stem Cell Transplantation (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Marta Medeot is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Marta Medeot collaborates with scholars based in Italy, United States and Finland. Marta Medeot's co-authors include Renato Fanin, Marta Lisa Battista, Miriam Isola, Leo Luznik, Christopher G. Kanakry, Richard J. Jones, Terry Furlong, Richard E. Champlin, Marcos J. de Lima and Wei Wei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marta Medeot

15 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Medeot Italy 10 356 185 154 86 80 17 541
Alice Garnier France 15 391 1.1× 220 1.2× 202 1.3× 56 0.7× 72 0.9× 73 653
Nan Young Lee South Korea 14 306 0.9× 174 0.9× 176 1.1× 56 0.7× 95 1.2× 41 545
Fábio R. Kerbauy Brazil 11 291 0.8× 153 0.8× 87 0.6× 58 0.7× 76 0.9× 45 474
Priscila Scheinberg United States 6 464 1.3× 134 0.7× 150 1.0× 35 0.4× 110 1.4× 8 534
Mohamad Sobh France 14 230 0.6× 131 0.7× 74 0.5× 68 0.8× 132 1.6× 61 476
Monica Soracco Italy 13 476 1.3× 213 1.2× 160 1.0× 77 0.9× 157 2.0× 24 640
Jesse Levin United States 4 449 1.3× 111 0.6× 296 1.9× 43 0.5× 86 1.1× 6 558
Karl G. Blume United States 8 369 1.0× 173 0.9× 132 0.9× 43 0.5× 47 0.6× 9 545
Cristina Skert Italy 14 392 1.1× 118 0.6× 188 1.2× 40 0.5× 44 0.6× 21 559
BS Andersson United States 9 379 1.1× 240 1.3× 162 1.1× 149 1.7× 95 1.2× 10 615

Countries citing papers authored by Marta Medeot

Since Specialization
Citations

This map shows the geographic impact of Marta Medeot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Medeot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Medeot more than expected).

Fields of papers citing papers by Marta Medeot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Medeot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Medeot. The network helps show where Marta Medeot may publish in the future.

Co-authorship network of co-authors of Marta Medeot

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Medeot. A scholar is included among the top collaborators of Marta Medeot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Medeot. Marta Medeot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Medeot, Marta, A. Michelazzi, Alessandra Poz, et al.. (2024). TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines. SHILAP Revista de lepidopterología. 5(4). 459–489.
2.
Tähtinen, Siri, Sara Feola, Cristian Capasso, et al.. (2020). Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer Research. 80(12). 2575–2585. 40 indexed citations
3.
Feola, Sara, Cristian Capasso, Manlio Fusciello, et al.. (2018). Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors. OncoImmunology. 7(8). e1457596–e1457596. 40 indexed citations
4.
Patriarca, Francesca, Davide Lazzarotto, Antonella Geromin, et al.. (2016). Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(2). 333–339. 33 indexed citations
5.
Marchi, Federico De, Marta Medeot, Renato Fanin, & Mario Tiribelli. (2016). How could patient reported outcomes improve patient management in chronic myeloid leukemia?. Expert Review of Hematology. 10(1). 9–14. 9 indexed citations
6.
Bonifacio, Massimiliano, Luigi Scaffidi, Gianni Binotto, et al.. (2015). Predictive Factors of Stable Deep Molecular Response in Chronic Myeloid Leukemia Patients Treated with Imatinib Standard Dose: A Study from the Gruppo Triveneto LMC. Blood. 126(23). 597–597. 13 indexed citations
7.
Kanakry, Christopher G., Paul V. O’Donnell, Terry Furlong, et al.. (2014). Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning. Journal of Clinical Oncology. 32(31). 3497–3505. 170 indexed citations
8.
Riera, Fernando, et al.. (2014). [Candidemia epidemiology in Córdoba Argentina. Surveillance study of five institutions].. PubMed. 71(2). 89–93. 5 indexed citations
9.
Riera, Fernando, et al.. (2014). Epidemiología de candidemia en Córdoba. Estudio de vigilancia de cinco instituciones. Revista de la Facultad de Ciencias Médicas de Córdoba. 71(2). 89–93. 1 indexed citations
10.
Patriarca, Francesca, Leo Luznik, Marta Medeot, et al.. (2014). Experts’ considerations on HLA‐haploidentical stem cell transplantation. European Journal Of Haematology. 93(3). 187–197. 19 indexed citations
11.
Tiribelli, Mario, Massimiliano Bonifacio, Gianni Binotto, et al.. (2013). EUTOS Score Predicts Optimal Response To Imatinib According To The Revised ELN Recommendations Better Than Sokal Score: A Study From The “Gruppo Triveneto LMC”. Blood. 122(21). 4024–4024. 1 indexed citations
12.
Patriarca, Francesca, Marta Medeot, Miriam Isola, et al.. (2013). Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Transplant Infectious Disease. 15(3). 259–267. 43 indexed citations
13.
14.
15.
Zaja, Francesco, Nicola Vianelli, Stefano Volpetti, et al.. (2010). Low‐dose rituximab in adult patients with primary immune thrombocytopenia. European Journal Of Haematology. 85(4). 329–334. 97 indexed citations
16.
Patriarca, Francesca, Venerino Poletti, Ulrich Costabel, et al.. (2009). Clinical Presentation, Outcome and Risk Factors of Late-Onset Non- Infectious Pulmonary Complications After Allogeneic Stem Cell Transplantation. Current Stem Cell Research & Therapy. 4(2). 161–167. 12 indexed citations
17.
Medeot, Marta, Francesco Zaja, Nicola Vianelli, et al.. (2008). Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long‐term follow‐up results. European Journal Of Haematology. 81(3). 165–169. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Garnier Breakdown of academic impact, for papers by Nan Young Lee Breakdown of academic impact, for papers by Fábio R. Kerbauy Breakdown of academic impact, for papers by Priscila Scheinberg Breakdown of academic impact, for papers by Mohamad Sobh Breakdown of academic impact, for papers by Monica Soracco Breakdown of academic impact, for papers by Jesse Levin Breakdown of academic impact, for papers by Karl G. Blume Breakdown of academic impact, for papers by Cristina Skert Breakdown of academic impact, for papers by BS Andersson
Rankless by CCL
2026